Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 6,128 | 51,625 | 827 | 0 | 15,087 |
| Gross Profit | 6,128 | 51,625 | 827 | N/A | 15,087 |
| Operating Expenses | 191,211 | 150,663 | 57,054 | 19,966 | 116,447 |
| Operating Income | -185,083 | -99,038 | -56,227 | -19,966 | -101,360 |
| Interest Expense | 0 | 0 | 0 | 33 | 0 |
| Other Income | 4,809 | -170 | -27,398 | -26,520 | 5,220 |
| Pre-tax Income | -180,274 | -99,208 | -83,625 | -46,519 | -96,140 |
| Income Tax | 4,341 | 2,093 | -2,003 | N/A | -783 |
| Net Income Continuous | -187,865 | -102,937 | -81,622 | -46,519 | -95,357 |
| Net Income | $-187,865 | $-102,937 | $-81,622 | $-46,519 | $-95,357 |
| EPS Basic Total Ops | -2.92 | -2.26 | -6.20 | -25.48 | -6.05 |
| EPS Basic Continuous Ops | -2.92 | -2.26 | -6.20 | -25.48 | -6.05 |
| EPS Diluted Total Ops | -2.92 | -2.26 | -6.20 | -25.48 | -6.05 |
| EPS Diluted Continuous Ops | -2.92 | -2.26 | -6.20 | -25.48 | -6.05 |
| EPS Diluted Before Non-Recurring Items | -2.92 | -1.91 | -6.06 | -5.15 | -5.80 |
| EBITDA(a) | $-180,108 | $-94,075 | $-54,787 | $-19,745 | $-93,482 |